|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Current assets | |||||||||||||||
| Cash | |||||||||||||||
| Restricted cash - held in Trust Account | |||||||||||||||
| Due from Sponsor | |||||||||||||||
| Franchise tax receivable | |||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||
| Total current assets | |||||||||||||||
| Cash and Investments held in Trust Account | |||||||||||||||
| Class A common stock subject to possible redemption | |||||||||||||||
| Total cash and Investments held in Trust Account | |||||||||||||||
| Deferred tax asset | |||||||||||||||
| Total Assets | |||||||||||||||
| Liabilities, Common Stock Subject to Possible Redemption and Stockholders' Deficit | |||||||||||||||
| Current liabilities | |||||||||||||||
| Accounts payable and accrued expenses | |||||||||||||||
| Franchise tax payable | |||||||||||||||
| Due to related party | |||||||||||||||
| Related party | |||||||||||||||
| Total due to related party | |||||||||||||||
| Franchise tax payable | |||||||||||||||
| Class A common stock pending redemption (64,453 shares) | |||||||||||||||
| Income taxes payable | |||||||||||||||
| Promissory note - related party | |||||||||||||||
| Excise tax payable | |||||||||||||||
| Derivative liability | |||||||||||||||
| Promissory note | |||||||||||||||
| Related party | |||||||||||||||
| Liminatus | |||||||||||||||
| Other affiliates | |||||||||||||||
| Total related party | |||||||||||||||
| Total promissory note | |||||||||||||||
| Total current liabilities | |||||||||||||||
| Deferred underwriting fee payable | |||||||||||||||
| Warrant liability | |||||||||||||||
| Total Liabilities | |||||||||||||||
| Class A common stock subject to possible redemption, 174,477 and 406,609 shares at redemption value of $10.07 and $9.96 at December 31, 2024 and December 31, 2023, respectively | |||||||||||||||
| Class A common stock subject to possible redemption | |||||||||||||||
| Total class A common stock subject to possible redemption, 174,477 and 406,609 shares at redemption value of $10.07 and $9.96 at December 31, 2024 and December 31, 2023, respectively | |||||||||||||||
| Stockholders' Deficit | |||||||||||||||
| Common stock | |||||||||||||||
| Class A common stock | |||||||||||||||
| Class A common stock not subject to possible redemption | |||||||||||||||
| Total class A common stock | |||||||||||||||
| Class B common stock | |||||||||||||||
| Extension deposits due from Sponsor | |||||||||||||||
| Additional paid-in capital | |||||||||||||||
| Accumulated deficit | |||||||||||||||
| Total Stockholders' Deficit | |||||||||||||||
| Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders' Deficit | |||||||||||||||
Loading...
